Drug Pipeline

MenACYW conjugate vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
0
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07135986 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal… Meningococcal Infection Active, Not Recruiting
Phase 2
NCT07320716 Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children Diarrhoea Not Yet Recruiting
NCT07183371 A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in… Malaria,Falciparum Active, Not Recruiting
NCT06213506 A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine… Salmonella Infections Active, Not Recruiting
Phase 1/2
NCT06647407 Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine… Meningococcal Immunization Active, Not Recruiting
Sponsors Running MenACYW conjugate vaccine Trials
GlaxoSmithKline (2) Sanofi Pasteur, a Sanofi Company (1) Sanofi (1) University of Oxford (1)
Get alerts when MenACYW conjugate vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free